UCKOXCYUCGQPRY-OWHBQTKESA-N
Compound with spectra: 1 NMR
| SpectraBase Compound ID | Ls7PxiaxBtm |
|---|---|
| InChI | InChI=1S/C35H38N4O3/c1-35(2,3)42-34(41)38-30(23-25-15-7-4-8-16-25)31-24-39(33(40)36-27-19-11-6-12-20-27)32(26-17-9-5-10-18-26)28-21-13-14-22-29(28)37-31/h4-22,30-32,37H,23-24H2,1-3H3,(H,36,40)(H,38,41)/t30-,31-,32+/m0/s1 |
| InChIKey | UCKOXCYUCGQPRY-OWHBQTKESA-N |
| Mol Weight | 562.7 g/mol |
| Molecular Formula | C35H38N4O3 |
| Exact Mass | 562.294391 g/mol |
| Enantiomer InChIKey | UCKOXCYUCGQPRY-IWWXRALLSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
2,10-Dibenzyl-1-hydroxy-10H-acridin-9-one
2-(6-bromo-4-phenyl-2-(3,4,5-trimethoxyphenyl)-3(4H)-quinazolinyl)acetohydrazide
(4bR,11aR)-5,10,11a,12-tetrahydro-4bH-indeno[1,2-b][1,4]benzodiazepine-11-carboxylic acid ethyl ester
(S)-tert-Butyl (1-methyl-3-(2-(methylamino)-2-oxoethyl)-2-oxoindolin-3-yl)carbamate
1-((2S,3R,4S)-3-Pentyl-2-p-tolyl-1,2,3,4-tetrahydro-quinolin-4-yl)-pyrrolidin-2-one
1'-((2S,3S,4S)-3-Pentyl-2-p-tolyl-1,2,3,4-tetrahydroquinolin-4-yl)pyrrolidin-2'-one
2,2,4,7-tetramethyl-1-(phenoxyacetyl)-4-phenyl-1,2,3,4-tetrahydroquinoline
3-Phenyl-1H,3H-[1,2,4]triazino[6,1-b]quinazolin-2,4,10-trione
N3-Benzoyl-3'-O-(N3-benzoyl-3'-O-methoxyacetyl-5'-O-thymidinyl-methyl)-thymidine
4-[(1-[2-(2,5-dimethoxyanilino)-2-oxoethyl]-2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl)methyl]-N-(2-phenylethyl)cyclohexanecarboxamide
| Title | Journal or Book | Year |
|---|---|---|
| Expedient One-Pot Synthesis of Novel Chiral 2-Substituted 5-Phenyl-1,4-benzodiazepine Scaffolds from Amino Acid-Derived Amino Nitriles | The Journal of Organic Chemistry | 2003 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.